"AB City" is the parent company of two commercially and socially significant joint stock companies: AS "Repharm" and AS "Olpha". The conglomerate includes healthcare, pharmaceutical retail and wholesale, production companies and laboratory test service providers operating in the Baltic region with a total annual turnover of over EUR 500 million.
People and health are the focus for the businesses and brands represented by "AB City", producing medicines at "Olpha", providing services at "Mēness aptieka pharmacies", "Veselības centru apvienība" medical institutions, branches of "Centrālā laboratorija", the wholesaler "Recipe Plus" as well as plant-based medicines at "Rīgas Farmaceitiskā fabrika".
"AB City" group companies actively participate in supporting areas important to society and the economy, contributing to education, science, sports, culture, and healthcare. We donate and promote initiatives that improve mental health support, increase accessibility of services for patients, foster an active and healthy lifestyle, and enhance the qualifications of doctors and pharmacists. "AB City" companies have also created a special support program for teachers, awarding scholarships to new or aspiring teachers of chemistry, biology, and mathematics. We also pay special attention to supporting Ukraine. In recent years, "AB City" group companies have provided support through donations totaling more than 8.3 million euros, not including other forms of support.
We invest in society, building a sustainable and healthy future!
We believe that affordable health care means healthier society and happier people.
On August 7, during a regional visit, Minister of Welfare Reinis Uzulnieks visited one of the largest companies and employers in Olaine Municipality – the Latvian pharmaceutical manufacturer AS “Olpha.”
To promote a healthy lifestyle and sustainable urban development, public drinking water fountains have been set up at two active recreation sites in Olaine.
"Mēness aptieka" (AS "Sentor Farm aptiekas") invested more than 1.1 million euros in 2024 in the reconstruction of 16 pharmacies across different regions of the country